Adhesive capsulitis is a common cause of shoulder pain and limited movement. The objectives of this review were to assess the efficacy and safety of corticosteroid injections for adhesive capsulitis and to evaluate the optimum dose and anatomical site of injections. PubMed and CENTRAL databases were searched for randomised trials and a total of ten trials were included. Results revealed that corticosteroid injection is superior to placebo and physiotherapy in the short-term (up to 12 weeks). There was no difference in outcomes between corticosteroid injection and oral nonsteroidal anti-inflammatory drugs at 24 weeks. Dosages of intra-articular triamcinolone 20 mg and 40 mg showed identical outcomes, while subacromial and glenohumeral corticosteroid injections had similar efficacy. The use of corticosteroid injections is also generally safe, with infrequent and minor side effects. Physicians may consider corticosteroid injection to treat adhesive capsulitis, especially in the early stages when pain is the predominant presentation.
|Nongenital Herpes Simplex Virus (0)||2021.08.20|
|Corticosteroid injection for adhesive capsulitis in primary care: a systematic review of randomised clinical trials (0)||2021.08.19|
|Acute diarrhea (0)||2021.08.19|
|ISOLATED HYPERBILIRUBINEMIA (0)||2021.08.17|
|ELEVATED ALKALINE PHOSPHATASE (0)||2021.08.17|
|아이폰, 아이패드에서 쓸만한 의학 어플 정리 (0)||2011.06.13|